RESUMEN
The neuroprotective and vasodilatory effects of cinnamaldehyde have been widely studied and documented. On the basis of these findings, we hypothesized that cinnamaldehyde exhibits therapeutic effects on subarachnoid hemorrhage-induced early brain injury and cerebral vasospasm. Thirty-two adult male New Zealand white rabbits were randomly divided into four groups of eight rabbits: control, subarachnoid hemorrhage, subarachnoid hemorrhage + vehicle, and subarachnoid hemorrhage + cinnamaldehyde. An intraperitoneal dose of 50 mg/kg cinnamaldehyde was administered 5 min following an intracisternal blood injection, followed by three further daily injections at identical doses. The animals were sacrificed 72 h after subarachnoid hemorrhage was induced. The cross-sectional areas and arterial wall thicknesses of the basilar artery were measured and hippocampal degeneration scores were evaluated. Treatment with cinnamaldehyde was effective in providing neuroprotection and attenuating cerebral vasospasm after subarachnoid hemorrhage in rabbits. It effectively increased the cross-sectional areas of the basilar artery and reduced the arterial wall thickness; in addition, hippocampal degeneration scores were lower in the cinnamaldehyde group. The findings of this study showed, for the first time to our knowledge, that cinnamaldehyde exhibits neuroprotective activity against subarachnoid hemorrhage-induced early brain injury and that it can prevent vasospasm. Potential mechanisms underlying the neuroprotection and vasodilation were discussed. Cinnamaldehyde could play a role in subarachnoid hemorrhage treatment.
Asunto(s)
Acroleína/análogos & derivados , Degeneración Nerviosa/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Hemorragia Subaracnoidea/tratamiento farmacológico , Vasoespasmo Intracraneal/tratamiento farmacológico , Acroleína/farmacología , Acroleína/uso terapéutico , Animales , Arteria Basilar/efectos de los fármacos , Arteria Basilar/patología , Modelos Animales de Enfermedad , Hipocampo/efectos de los fármacos , Hipocampo/patología , Masculino , Degeneración Nerviosa/patología , Fármacos Neuroprotectores/farmacología , Conejos , Hemorragia Subaracnoidea/complicaciones , Hemorragia Subaracnoidea/patología , Vasoespasmo Intracraneal/etiología , Vasoespasmo Intracraneal/patologíaRESUMEN
BACKGROUND AND AIM: Late-onset seizure due to intracerebral needle is a rare entity. Most of them were clinically asymptomatic and rarely presented with seizure. Sewing needles are used in homicidal attempt in infancy or early childhood before the closure of the fontanels. Because of sociologic, politic, and scientific deficiencies subject remained untouched. We tried shedding some light on this ambiguous phenomenon. MATERIAL AND METHODS: We report a 54-year-old man who was admitted to our neurosurgery outpatient department with epilepsy due to a sewing needle located in the left frontal lobe of the brain and made extensive literature review. RESULT: Patient's physical and neurological examinations were completely normal. All biochemical and hematological tests were normal. Cranial tomography demonstrated a linear density at the left frontal lobe compatible with a sewing needle. Patient was followed-up with antiepileptic treatment with no seizure. Sixty cases from up-to-date literature and past cases were reviewed. Patients' ages differ from 4 days to 70 years. Our review showed four cases treated with antibiotics, 19 patients went to surgery, and others just followed-up with antiepileptic and other drugs. CONCLUSION: Literature needs an autopsy series for a more intimate estimation. Due to psychosocial and legitimacy problems, matter should be handled cautiously and law enforcement agencies must be informed. Follow-up with medication is the first line of treatment with asymptomatic patients. Treatment is dictated by clinic onset, physical examination, and patient consent.
Asunto(s)
Cuerpos Extraños/complicaciones , Lóbulo Frontal , Agujas/efectos adversos , Convulsiones/etiología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
OBJECTIVES: A number of chemical and biological factors, including mesenchymal stem cells (MSCs), have been developed to enhance nerve regeneration by introduction through a variety of nerve conduits. This study was designed to assess the efficacy of using chitosan-coated poly-3-hydroxybutyrate (PHB) nerve conduits seeded with human bone marrow-derived MSCs (hMSC-bm) to augment repair in an experimental rat model of sciatic nerve injury. METHODS: A total of 30 rats were randomly assigned to one of three groups (n = 10). In each rat, a 10 mm segment of the sciatic nerve was removed and was replaced by a chitosan-coated PHB conduit seeded with hMSC-bm (PHB/chitosan-hMSC-bm group), a chitosan-coated PHB conduit (PHB/chitosan group), or an autograft (autograft group) as the control. The results were evaluated 8 weeks postoperatively by observation, electromyography and histologic examination with light microscopy and immunostaining. RESULTS: Histologic examination showed that both PHB/chitosan-hMSC-bm conduits and PHB/chitosan conduits led the damaged axons through the injured area. When the effects were compared, the results with the PHB/chitosan-hMSC-bm conduits were superior to those with the PHB/chitosan conduits (p < 0.05) but not as successful as with the autologous nerve grafts (p < 0.05). CONCLUSION: PHB/chitosan-hMSC-bm nerve conduits may be a useful artificial guide for nerve regeneration.
Asunto(s)
Materiales Biocompatibles/uso terapéutico , Quitosano/uso terapéutico , Hidroxibutiratos/uso terapéutico , Células Madre Mesenquimatosas/fisiología , Regeneración Nerviosa/efectos de los fármacos , Poliésteres/uso terapéutico , Neuropatía Ciática/cirugía , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Electromiografía , Potenciales Evocados Motores/efectos de los fármacos , Potenciales Evocados Motores/fisiología , Masculino , Prohibitinas , Ratas , Ratas Wistar , Caminata/fisiologíaRESUMEN
The present study prompted the second attempts to evaluate biochemical responses of filamentous algae under different physico-chemical variables in various water bodies in Turkey. These variables were investigated by use of multivariate approach in the years of 2013 (May and November) and 2014 (May and October). Studied ecoregions had the different geographic position, climate, land-use, and anthropogenic activities, could strongly affect physico-chemical variables of water bodies, which caused to change or regulate in algal biomass composition due to the different response of filamentous species. Besides, biochemical responses of species changed at different sampling times and stations. Multivariate analyses indicated that temperature, heavy metals, and nutrient contents of aquatic systems were found to be major variables driving the spatial and temporal occurrence and biochemical contents of filamentous species. Total protein and pigment production by filamentous algae were high in water bodies having high nutrients, whereas they were low in high heavy metal contents. Amount of malondialdehyde (MDA), H2O2, total thiol group, total phenolic compounds, proline, total carbohydrate, and bioaccumulation of metals by filamentous algae were closely related with heavy metal contents of water bodies, indicated by the multivariate approach. Significant increase in aforementioned biochemical compounds with a distinct range of habitats and sensitive-tolerance to environmental conditions could make them highly valuable indicators.
Asunto(s)
Chlorophyta/crecimiento & desarrollo , Monitoreo del Ambiente/métodos , Agua Dulce/análisis , Metales Pesados/análisis , Spirogyra/crecimiento & desarrollo , Contaminantes Químicos del Agua/análisis , Biomasa , Ecosistema , Agua Dulce/química , Metales Pesados/metabolismo , Estaciones del Año , Turquía , Contaminantes Químicos del Agua/metabolismoRESUMEN
To the best of our knowledge, any study about biochemical response of filamentous algae in the complex freshwater ecosystems has not been found in the literature. This study was designed to explore biochemical response of filamentous algae in different water bodies from May 2013 to October 2014, using multivariate approach in the South East of Turkey. Environmental variables were measured in situ: water temperature, oxygen concentration, saturation, conductivity, salinity, pH, redox potential, and total dissolved solid. Chemical variables of aqueous samples and biochemical compounds of filamentous algae were also measured. It was found that geographic position and anthropogenic activities had strong effect on physico-chemical variables of water bodies. Variation in environmental conditions caused change in algal biomass composition due to the different response of filamentous species, also indicated by FTIR analysis. Biochemical responses not only changed from species to species, but also varied for the same species at different sampling time and sampling stations. Multivariate analyses showed that heavy metals, nutrients, and water hardness were found as the important variables governing the temporal and spatial succession and biochemical compounds. Nutrients, especially nitrate, could stimulate pigment and total protein production, whereas high metal content had adverse effects. Amount of malondialdehyde (MDA), H2O2, total thiol groups, total phenolic compounds, proline, total carbohydrate, and metal bioaccumulation by filamentous algae could be closely related with heavy metals in the ecosystems. Significant increase in MDA, H2O2, total thiol group, total phenolic compounds, and proline productions by filamentous algae and chlorosis phenomenon seemed to be an important strategy for alleviating environmental factors-induced oxidative stress as biomarkers.
Asunto(s)
Ecosistema , Agua Dulce/química , Metales Pesados/farmacología , Nitratos/farmacología , Algas Marinas/efectos de los fármacos , Contaminantes Químicos del Agua/farmacología , Calidad del Agua , Animales , Biomasa , Exposición a Riesgos Ambientales , Estrés Oxidativo , Algas Marinas/metabolismo , Turquía , Agua/químicaRESUMEN
The biosorption of phosphorus in the form of orthophosphate (Po) from wastewater using biomass as the sorbent is of potential importance because the Po-loaded biomass could be applied in the agricultural sector as fertilizer and soil conditioner. However, biomass generally displays a very low affinity for Po sorption and therefore biomass surface modification is required. In the present study, the biomass (as model grinded leaves of Phragmites sp. were used) was pretreated with Ca(OH)2 to enhance Po biosorption capacity (qe). The results indicate that the alkaline pretreatment resulted in a modification of surface functional groups. It was concluded that the main sorption mechanisms were ligand exchange and electrostatic attraction. A series of experiments were conducted to investigate the performance of the pretreated biomass for Po uptake under various conditions. Isotherm and thermodynamic studies were also applied and analyzed. The biosorption process was best described by the pseudo-second order kinetic model and Langmuir isotherm, which gave a qmax of 12.27mgP/g at 25°C and pH7. The Ca(OH)2 treated Phragmites biomass applied in this study for Po recovery may present some potential advantages in terms of costs and environmental impact.
Asunto(s)
Hidróxido de Calcio/química , Fosfatos/metabolismo , Poaceae/metabolismo , Contaminantes Químicos del Agua/metabolismo , Adsorción , Biodegradación Ambiental , Biomasa , TermodinámicaRESUMEN
Much attention has been given to the use of microalgae to produce functional foods that have valuable bioactive chemicals, including essential amino acids, polyunsaturated fatty acids, vitamins, carotenoids, fiber, and minerals. Microalgal biomasses are increasingly being used to improve the nutritional values of foods because of their unique nutrient compositions that are beneficial to human health. Their protein content and amino acid composition are the most important components. The microalgal biomass used in the therapeutic supplement industry is dominated by bio-compounds like astaxanthin, ß-carotene, polyunsaturated fatty acids like eicosapentaenoic acid and docosahexaenoic acid, and polysaccharides such as ß-glucan. The popularity of microalgal supplements is growing because of the health benefits of their bioactive substances. Moreover, some microalgae, such as Dunaliella, Arthrospira (Spirulina), Chlorella, and Haematococcus, are commonly used microalgal species in functional food production. The incorporation of microalgal biomass leads not only to enhanced nutritional value but also to improved sensory quality of food products without altering their cooking or textural characteristics. Microalgae, because of their eco-friendly potential, have emerged as one of the most promising and novel sources of new functional foods. This study reviews some recent and relevant works, as well as the current challenges for future research, using different methods of chemical modification in foods with the addition of a few commercial algae to allow their use in nutritional and sensory areas. It can be concluded that the production of functional foods through the use of microalgae in foods has become an important issue.
RESUMEN
A controlled release system that enables the sunlight-triggered release of a model agrochemical, abamectin (abm), is presented. The release system consists of polydopamine functionalized halloysite nanotubes (HNT-PDA) utilized as photothermal nanocarriers to encapsulate 25 wt % abm and 37 wt % lauric acid (LA), a phase change material, that acts as a heat-activable gatekeeper stopping or facilitating the abm release. When exposed to sunlight for 20 min at 1 and 3 sun light density, the temperature of the photothermal nanocarriers reaches 51 and 122 °C, respectively, which triggers the melting of LA and the consequent release of abm from the nanocarriers. Abm was shown to be released gradually over a period of 10 days when nanohybrids were exposed to sunlight for 6 h per day and to remain stable and kill Myzus persicae (Sulzer) (Hemiptera: Aphididae), green peach aphids, at a mortality rate of over 70% for at least 10 days. Aqueous dispersions of the LA/abm@HNT-PDA nanohybrids were studied in terms of their potential as aqueous sprayable pesticide nanoformulations and presented over 30% suspensibility, 36 mg/cm2 foliar retention, strong rainwater resistance, and a 50% mortality rate for M. persicae at a concentration of 9 mg/mL. The proposed sunlight-activated controlled release system based on photothermal, LA-functionalized HNT-PDA nanocarriers holds great potential as controlled release pesticide nanoformulations.
RESUMEN
This radiologic work aimed to display the alteration in the superior orbital fissure (SOF) morphology in the pediatric population with advancing age. This pediatric examination consisted of computed tomography images of 180 subjects (90 males/90 females) aged 1-18 years. The length (SOF-L) and width (SOF-W) of SOF were measured, and its shape was noted. SOF-L and SOF-W were measured as 16.04 ± 2.34 mm and 5.35 ± 1.01 mm, respectively. SOF-L was similar in infancy and early childhood periods, but then decreased up to postpubescent period. This measurement increased significantly in postpubescent period. SOF-W did not show important change from infancy period up to postpubescent period. After that, it increased significantly in postpubescent period. Seven configurations regarding SOF shape were observed: the straight type in 20.8% out of 360 SOFs, eight-shaped type in 12.2%, key-shaped type in 14%, racket-shaped type in 18.6%, narrow type in 7.2%, triangular type in 14.7%, and curved type in 12.5%. SOF shape was not affected by sex (p = 0.150) and side (p = 0.919). Linear functions were calculated as y = 16.310-0.028 × age for SOF-L, and as y = 4.886 + 0.048 × age for SOF-W. SOF-L showed an irregular pattern of first decreasing and then increasing, during the transition from 1 year to 18 years. SOF-W displayed an irregular pattern of increasing with advancing ages in children. Our linear functions representing the growth pattern of SOF in children may be useful to estimate SOF size.
RESUMEN
Effects of cadmium (Cd(2+)) on biomass, pigmentation (chlorophyll a, b, and total carotene), malondialdehyde (MDA), and proline productions by Scenedesmus quadricauda var. longispina were investigated. Cadmium had inhibitory effect on the productions of biomass and pigmentation. Significant differences were found in pigment content among groups. On the other hand, Cd(2+) had a simulative effect on the production of MDA and proline by the alga. FTIR-ATR spectroscopy was used to examine active groups of algal biomass before and after Cd(2+) exposure. Results confirmed that amino, amide, and anionic groups had significant role on the biosorption of Cd(2+) by the alga. Increased accumulation of MDA and proline seemed to be an important strategy for alleviating metal-induced oxidative stress in S. quadricauda var. longispina.
Asunto(s)
Cadmio/toxicidad , Clorofila/metabolismo , Malondialdehído/metabolismo , Prolina/metabolismo , Scenedesmus/efectos de los fármacos , Contaminantes Químicos del Agua/toxicidad , Clorofila A , Scenedesmus/fisiologíaRESUMEN
This study aimed to assess the survival of probiotic cultures in kefir. Kefir is a fermented dairy product, and in this study we incorporated nutritionally rich flaxseed mucilage and gum arabic as a prebiotic, then monitored for improvement in the the viability of Lactobacillus acidophilus and Bifidobacterium lactis. In addition, some physicochemical variables of kefir were investigated. The addition of flaxseed mucilage and gum arabic significantly (p Ë 0.05) increased the growth of both Lactobacillus acidophilus and Bifidobacterium lactis compared to the control. Samples enriched with flaxseed mucilage and gum arabic had significantly (p Ë 0.05) reduced pH and increased viscosity. Flaxseed mucilage and gum arabic significantly (p Ë 0.05) changed the color parameters L*, a*, and b*. However, as the concentration of flaxseed mucilage increased, the L* value decreased. Moreover, adding flaxseed mucilage and gum arabic into kefir increased (p Ë 0.05) the protein content. These results showed that flaxseed mucilage and gum arabic could be used to increase the survival of probiotic cultures in kefir without changing its physicochemical properties.
RESUMEN
BACKGROUND: Mildronate is a useful anti-ischemic agent and has antiinflammatory, antioxidant, and neuroprotective activities. The aim of this study is to investigate the potential neuroprotective effects of mildronate in the experimental rabbit spinal cord ischemia/reperfusion injury (SCIRI) model. METHODS: Rabbits were randomized into 5 groups of 8 animals as groups 1 (control), 2 (ischemia), 3 (vehicle), 4 (30 mg/kg methylprednisolone [MP]), and 5 (100 mg/kg mildronate). The control group underwent only laparotomy. The other groups have the spinal cord ischemia model by a 20-minute aortic occlusion just caudal to the renal artery. The malondialdehyde and catalase levels and caspase-3, myeloperoxidase, and xanthine oxidase activities were investigated. Neurologic, histopathologic, and ultrastructural evaluations were also performed. RESULTS: The serum and tissue myeloperoxidase, malondialdehyde, and caspase-3 values of the ischemia and vehicle groups were statistically significantly higher than those of the MP and mildronate groups (P < 0.001). Serum and tissue catalase values of the ischemia and vehicle groups were statistically significantly lower than those of the control, MP, and mildronate groups (P < 0.001). The histopathologic evaluation showed a statistically significantly lower score in the mildronate and MP groups than in the ischemia and vehicle groups (P < 0.001). The modified Tarlov scores of the ischemia and vehicle groups were statistically significantly lower than those of the control, MP, and mildronate groups (P < 0.001). CONCLUSIONS: This study presented the antiinflammatory, antioxidant, antiapoptotic, and neuroprotective effects of mildronate on SCIRI. Future studies will elucidate its possible use in clinical settings in SCIRI.
Asunto(s)
Fármacos Neuroprotectores , Daño por Reperfusión , Isquemia de la Médula Espinal , Animales , Conejos , Catalasa/farmacología , Peroxidasa , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Caspasa 3 , Médula Espinal/patología , Isquemia de la Médula Espinal/patología , Metilprednisolona , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/patología , Isquemia , Malondialdehído/farmacología , Modelos Animales de EnfermedadRESUMEN
In this study, the contact toxicity of spinetoram on three different surfaces, concrete, ceramic floor tile and laminate flooring, against Acanthocelides obtectus (Say.) (Coleoptera: Chrysomelidae) was evaluated in laboratory bioassays. Different concentrations were evaluated ranging from 0.0025 to 0.05 mg AI/cm2, against adults of A. obtectus. Adult mortality was measured after 1-, 3-, 5- and 7-day exposure. After 1-day exposure, the mortality was low on all surfaces, ranging from 0 to 27.2%. After 5- and 7-day exposure, spinetoram at concentrations of 0.01 mg/cm2 and above achieved 100% or close mortality on concrete and laminate flooring surface, whereas low concentrations (0.0025, 0.005 and 0.0075 mg AI/cm2) resulted in significantly lower mortality levels, ranging from 1.6 to 30.8%, than high concentrations. In the case of ceramic floor tile surface, spinetoram treatments at all tested concentrations did not result in 100% mortality. Significant differences were recorded among the surfaces, depending on concentrations and exposure intervals. After 3-, 5- and 7-day exposure, mortality levels on ceramic floor tile surface were generally higher at low concentrations than those on the concrete and laminate flooring surfaces, whereas those on concrete and laminate flooring surfaces were significantly higher at high concentrations than ceramic floor tile surface. These results indicate that spinetoram at 0.025 and 0.05 mg AI/cm2 achieve satisfactory control at relatively short exposures on common types of surfaces and thus can be used as an effective insecticide against A. obtectus.
RESUMEN
OBJECTIVE: The study objective was to compare gut microbiome diversity and composition in SARS-CoV-2 PCR-positive patients whose symptoms ranged from asymptomatic to severe versus PCR-negative exposed controls. DESIGN: Using a cross-sectional design, we performed shotgun next-generation sequencing on stool samples to evaluate gut microbiome composition and diversity in both patients with SARS-CoV-2 PCR-confirmed infections, which had presented to Ventura Clinical Trials for care from March 2020 through October 2021 and SARS-CoV-2 PCR-negative exposed controls. Patients were classified as being asymptomatic or having mild, moderate or severe symptoms based on National Institute of Health criteria. Exposed controls were individuals with prolonged or repeated close contact with patients with SARS-CoV-2 infection or their samples, for example, household members of patients or frontline healthcare workers. Microbiome diversity and composition were compared between patients and exposed controls at all taxonomic levels. RESULTS: Compared with controls (n=20), severely symptomatic SARS-CoV-2-infected patients (n=28) had significantly less bacterial diversity (Shannon Index, p=0.0499; Simpson Index, p=0.0581), and positive patients overall had lower relative abundances of Bifidobacterium (p<0.0001), Faecalibacterium (p=0.0077) and Roseburium (p=0.0327), while having increased Bacteroides (p=0.0075). Interestingly, there was an inverse association between disease severity and abundance of the same bacteria. CONCLUSION: We hypothesise that low bacterial diversity and depletion of Bifidobacterium genera either before or after infection led to reduced proimmune function, thereby allowing SARS-CoV-2 infection to become symptomatic. This particular dysbiosis pattern may be a susceptibility marker for symptomatic severity from SARS-CoV-2 infection and may be amenable to preinfection, intrainfection or postinfection intervention. TRIAL REGISTRATION NUMBER: NCT04031469 (PCR-) and 04359836 (PCR+).
Asunto(s)
COVID-19 , Microbiota , Bifidobacterium/genética , Estudios Transversales , Faecalibacterium , Humanos , SARS-CoV-2RESUMEN
Oral booster-single strain probiotic bifidobacteria could be a potential strategy for SARS-CoV-2. This study aims to evaluate the role of oral probiotic Bifidobacterium on moderate/severe SARS-CoV-2 inpatients. In this single-center study, we analyzed data of 44 moderate/severe inpatients with diagnosed COVID-19 in Istanbul Maltepe University Medical Faculty Hospital, 2020 from 1 November 2020 to 15 December 2020. Clinical and medication features were compared and analyzed between patients with or without probiotic. In result, 19 of the 44 patients (43.18%) who were administrated with oral booster-single strain probiotic were discharged with the median inpatient day of 7.6 days which were significantly shorter than those of patients without probiotic. There were significant differences in inpatient days, radiological improvement at day 6 and week 3, and reduction in interleukin-6 levels in those receiving oral probiotic therapy. Although the mortality rate was 5% in the probiotic group, it was 25% in the non-probiotic group. Booster-single strain probiotic bifidobacteria could be an effective treatment strategy for moderate/severe SARS-CoV-2 inpatients to reduce the mortality and length of stay in hospital.
Asunto(s)
Bifidobacterium , Tratamiento Farmacológico de COVID-19 , COVID-19 , Interleucina-6/sangre , Probióticos , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/inmunología , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/efectos adversos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Mortalidad , Probióticos/administración & dosificación , Probióticos/efectos adversos , Estudios Retrospectivos , SARS-CoV-2/efectos de los fármacos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Turquía/epidemiologíaRESUMEN
AIM: To analyze the spinal canal type and spinal structure of patients, to determine appropriate preoperative preparation and surgical procedures to prevent material malposition, which is the most common complication of thoracolumbar posterior transpedicular stabilization (TPTS) and is a determiner of its clinical outcomes. MATERIAL AND METHODS: A total of 214 cases were examined. TPTS procedures carried out on each thoracolumbar spine were evaluated. Twenty parameters were documented and retrospectively examined in each patient. RESULTS: Laminectomy is not helpful for healing unless there is spinal compression and ligamentotaxis is beneficial for healing. The correlation between the structure of the spinal canal and defective screw delivery found (p < 0.05). CONCLUSION: The spinal structure formed around the canal should be the first form to evaluate while TPTS applications to protect the spinal cord, which is the focal point of the spinal structure.
Asunto(s)
Canal Medular/anatomía & histología , Fusión Vertebral/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Vértebras Lumbares/cirugía , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Vértebras Torácicas/cirugía , Resultado del Tratamiento , Adulto JovenRESUMEN
COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a 'cytokine storm'. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the 'cytokine storm' through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy.
Asunto(s)
Bifidobacterium , Infecciones por Coronavirus/terapia , Neumonía Viral/terapia , Probióticos/uso terapéutico , COVID-19 , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/microbiología , Microbioma Gastrointestinal , Humanos , Pandemias , Neumonía Viral/inmunología , Neumonía Viral/microbiologíaRESUMEN
AIM: To investigate the effects of an anti-ischemic agent, mildronate, on subarachnoid hemorrhage-induced vasospasm. MATERIAL AND METHODS: Rabbits were randomly divided into four groups: control, subarachnoid hemorrhage (SAH), vehicle, and mildronate (n=8 animals per group). In the treatment group, 200 mg/kg of mildronate were intraperitoneally administered 5 minutes after the procedure and continued for 3 days as daily administrations of the same dose. At the end of the third day, the cerebrum, cerebellum, and brain stem were perfused, fixated, and removed for histopathological examination. Tissues were examined for arterial wall thickness, luminal area, and hippocampal neuronal degeneration. RESULTS: Mildronate group showed significantly increased luminal area and reduced wall thickness of the basilar artery compared with the subarachnoid hemorrhage group. In addition, the hippocampal cell degeneration score was significantly lower in the mildronate group than in the SAH and vehicle groups. CONCLUSION: These results show that mildronate exerts protective effects against SAH-induced vasospasm and secondary neural injury.
Asunto(s)
Metilhidrazinas/farmacología , Hemorragia Subaracnoidea , Vasoespasmo Intracraneal , Animales , Arteria Basilar/efectos de los fármacos , Modelos Animales de Enfermedad , Hipocampo/efectos de los fármacos , Masculino , Fármacos Neuroprotectores/farmacología , Conejos , Vasodilatadores/farmacología , Vasoespasmo Intracraneal/etiologíaRESUMEN
OBJECTIVE: Vasospasm after subarachnoid hemorrhage (SAH) plays a vital role in the development of delayed cerebral ischemia. Anti- vascular endothelial growth factor (VEGF) antibodies, like bevacizumab (BEV), may attenuate VEGF-stimulated angiogenesis, reduced vascular cell proliferation, and improve vasospasm after SAH. METHODS: Thirty-two adult male New Zealand white rabbits were randomly divided into 4 groups of 8 rabbits in each group: group 1 (control); group 2 (SAH); group 3 (SAH + vehicle); and group 4 (SAH + BEV). BEV (5 mg/kg, intraperitoneally) was administered 5 minutes after the intracisternal blood injection and continued for 72 hours once per day in the same dose for group 4. Animals were sacrificed 72 hours after SAH. Basilar artery cross-sectional areas, arterial wall thicknesses, and hippocampal degeneration scores were evaluated in all groups. RESULTS: VEGF is associated with the narrowing of the basilar artery. Treatment with BEV statistically significantly increased the cross-sectional area of the basilar artery when compared with the SAH and the vehicle groups. Basilar artery wall thicknesses in the BEV group was statistically significant smaller than in the SAH and vehicle groups. The hippocampal degeneration scores for the BEV and control groups were similar and significantly lower than those for the SAH and vehicle groups. CONCLUSIONS: Cellular proliferation and subsequent vessel wall thickening is a reason to delay cerebral ischemia and deterioration of the neurocognitive function. Intraperitoneal administration of BEV was found to attenuate cerebral vasospasm and prevent delayed cerebral ischemia and improve neurocognitive function after SAH in rabbits.
Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Bevacizumab/farmacología , Hemorragia Subaracnoidea/complicaciones , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Vasoespasmo Intracraneal/etiología , Animales , Isquemia Encefálica/etiología , Modelos Animales de Enfermedad , Masculino , ConejosRESUMEN
BACKGROUND: Vigabatrin, an antiepileptic drug, increases the level of gamma aminobutyric acid in the brain by inhibiting its catabolism. Because gamma aminobutyric acid has been proved to have vasodilatory effects, in the present study, we investigated the effect of vigabatrin to treat experimental subarachnoid hemorrhage (SAH)-induced vasospasm. METHODS: A total of 30 New Zealand white rabbits were divided into 3 groups of 10 each: the control group, SAH group, and vigabatrin group. Experimental SAH was established by injection of autologous arterial blood into the cisterna magna. In the vigabatrin group, the rabbits were administered vigabatrin for 3 days after induction of the SAH. The first dose of vigabatrin was given 2 hours after SAH induction. A daily dose of 500 mg/kg vigabatrin was administered intraperitoneally. After 3 days, the rabbits were sacrificed, and the brains were removed, together with the cerebellum and brainstem. The basilar artery wall thickness and lumen areas were measured. The neuronal degeneration in the hippocampus (CA1, CA3, and dentate gyrus) was also evaluated. RESULTS: The arterial wall thickness of the vigabatrin group was less than that in the SAH group (P < 0.001), and the mean luminal area of the vigabatrin group was greater than that in the SAH group (P < 0.001). Additionally, the hippocampal neuronal degeneration score of the vigabatrin group was lower than that of the SAH group (P < 0.001). CONCLUSION: These findings have indicated that vigabatrin has a vasodilatory effect in an experimental SAH model in the rabbit. Moreover, it showed a neuroprotective effect in the hippocampal neurons against secondary injury induced by SAH.